Sinai Intellectual Cedars - Apr 5, 2022 Form 4 Insider Report for Prometheus Biosciences, Inc. (RXDX)

Role
10%+ Owner
Signature
Timothy K. Andrews, attorney-in-fact
Stock symbol
RXDX
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 05:49 PM
Previous filing
Jun 25, 2021
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXDX Common Stock Other $0 -142K -2.84% $0.00 4.87M Apr 5, 2022 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the transfer of an aggregate total of 142,376 shares of the Issuer's common stock held by Cedars Sinai Intellectual Property Company (CSIPC) to three inventors of Cedars-Sinai Medical Center (CSMC) as compensation for their services.
F2 The securities reported herein are held directly by CSIPC, a wholly owned subsidiary of CSMC.